Chirfi Guindo - Aug 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Jon Filderman, as attorney-in-fact for Chirfi Guindo
Stock symbol
MRK
Transactions as of
Aug 3, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 04:04 PM
Previous filing
Apr 28, 2023
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 2.7 Aug 3, 2022 Direct
holding MRK Common Stock-401(k) Plan 51.2 Aug 3, 2022 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +111K $0.00 111K Aug 3, 2022 Common Stock 111K Direct F1, F2

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.